HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
3Y Annualised
N/A
0.13% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
1.77%
0.13% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
5 years 5 months
5 years 3 months
9 years 7 months
Fund info
Fund size
₹1875.89 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹100
Exit load
0%
In respect of eachpurchase/switch-in ofunits, an Exit load of1% is payable if unitsare redeemed/switched-out within 30days from the date ofallotment. No Exit Load ispayable if units areredeemed / switchedout after 30 days fromthe date of allotment.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Kotak Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
2nd
Kotak Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
3rd
Kotak Healthcare Fund Direct Growth
4th
Kotak Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl
5th
Kotak Healthcare Fund Regular Reinvestment Inc Dist cum Cap Wdrl
9th
HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
Fund Managers
About HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is a Equity mutual fund scheme from HDFC Asset Management Co Ltd. This fund has been in existence for 2 years, having been launched on 2023-10-04. HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has ₹1875.89 Cr worth of assets under management (AUM) as of Sat Feb 14 2026. The latest Net Asset Value (NAV) of HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl as of Fri Feb 13 2026 is ₹17.678. The fund has an expense ratio of 0.94%, which is medium comparable to most other Equity funds.
HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl returns for the last 1 year are 13.76%. Since launch, it has delivered 28.35% average annual returns.
The HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl.
- Sun Pharmaceuticals Industries Ltd: 9.75%
- Divi's Laboratories Ltd: 8.57%
- Glenmark Pharmaceuticals Ltd: 6.76%
- Lupin Ltd: 6.52%
- Alkem Laboratories Ltd: 6.42%
AMC Information
| Name | HDFC Asset Management Co Ltd |
|---|---|
| Founding Date | 2023-10-04 |
| cliser@hdfcfund.com | |
| Phone | +91 22 66316333 |
| Website | www.hdfcfund.com |
| Address | HDFC Asset Management Company Limited,“HUL House”, 2nd Floor,,H.T. Parekh Marg,165-166, Backbay Reclamation,,Churchgate, |
Tax Implications of HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from HDFC Asset Management Co Ltd
Alternative StrategiesArbitrage Fund
3Y CAGR
7.03%
expense ratio
0.93%
fund size
₹24502.54 Cr
Fixed IncomeGovernment Bond
3Y CAGR
6.76%
expense ratio
0.89%
fund size
₹2740.18 Cr
Fixed IncomeMedium to Long Duration
3Y CAGR
6.70%
expense ratio
1.39%
fund size
₹880.01 Cr
EquityEquity - Infrastructure
3Y CAGR
28.40%
expense ratio
1.15%
fund size
₹2366.20 Cr
AllocationFund of Funds
3Y CAGR
11.98%
expense ratio
0.33%
fund size
₹2569.28 Cr
Calculate Your Returns
Estimated Returns in 1 Years (Based on past 1Y returns)
₹0
Total Amount
₹0
